Related Experiment Videos
[Fistulous pyoderma caused by Serratia liquefaciens]
Summary
Human infections with Serratia liquefaciens are rare. This case study details a patient with fistulous pyoderma caused by this bacterium, successfully treated with sulfamethoxazole trimethoprim after antibiotic sensitivity testing.
Area of Science:
- Medical Microbiology
- Dermatology
Background:
- Human infections caused by Serratia liquefaciens are infrequently reported.
- Fistulous pyoderma is a chronic bacterial skin infection characterized by pus-discharging tracts.
Observation:
- A patient presented with skin lesions initially suspected to be dermal tuberculosis.
- Histological, microbiological, and X-ray examinations were conducted for diagnosis.
- Serratia liquefaciens was identified as the sole causative agent of the skin lesions through microbial culture.
Findings:
- The patient's skin lesions resolved completely following treatment.
- Sulfamethoxazole trimethoprim was the chosen antibiotic regimen for therapy.
- Antibiotic resistance and sensitivity testing are crucial for effective Serratia infection management.
Implications:
- This case highlights Serratia liquefaciens as a potential pathogen in complex skin infections.
- Effective treatment relies on accurate microbiological diagnosis and targeted antibiotic therapy.
- Further research may elucidate the prevalence and clinical spectrum of Serratia liquefaciens human infections.